# Evaluation of Lactobacillus Reuteri DSM 17938 + Vitamin D3 in the Prevention of RRI in Paediatric Patients

> **NCT04408443** · NA · TERMINATED · sponsor: **Noos S.r.l.** · enrollment: 200 (actual)

## Conditions studied

- Recurrent Respiratory Tract Infections

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus reuteri DSM 17938 + Vitamine D3
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04408443
- **Lead sponsor:** Noos S.r.l.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-25
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 200 (ACTUAL)
- **Why stopped:** No enrollment due COVID PANDEMIA
- **Last updated:** 2023-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04408443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04408443, "Evaluation of Lactobacillus Reuteri DSM 17938 + Vitamin D3 in the Prevention of RRI in Paediatric Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04408443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*